Abstract
Velo-cardio-facial syndrome (VCFS) is characterized by a high prevalence of depression and anxiety disorders in childhood and adolescence. These disorders are a source of great impairment in everyday functioning, as well as important risk factors for the emergence of later psychotic disorders. Impairment in daily and social functioning as well as loss of IQ throughout growth are also are well-established correlates of the VCFS. This study aimed to confirm the high prevalence of depression and anxiety disorders. The second objective was to ascertain the correlation between anxious and depressive symptoms and the decline in adaptive and cognitive functioning. A total of 73 children and adolescents with VCFS (mean age 11.9 years) underwent psychiatric evaluation. Subjects were further divided into four age groups: ages 6–9, 9–12, 12–15 and 15–18 years. Assessments measuring intelligence, anxious and depressive symptoms, and adaptation skills reported by parents were submitted to a subsample of 62 children (mean age 12.2 years); 62.2 % of the sample showed an anxiety disorder, specific phobia being the most represented at all ages. Lifetime depression concerned 27 % of the sample, peaking at age 12–15 years. Anxious and depressive symptoms and low IQ were significantly associated with low adaptive functioning. Anxiety and depression are common disorders in children and adolescents with VCFS and have a great impact on adaptive functioning. Clinicians should pay great attention to diagnosis and treatment.
Similar content being viewed by others
Abbreviations
- DICA:
-
Diagnostic Interview for Children and Adolescents
References
Antshel KM, Fremont W, Roizen NJ, Shprintzen R, Higgins AM, Dhamoon A, Kates WR (2006) ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 45:596–603
Feinstein C, Eliez S, Blasey C, Reiss AL (2002) Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry 51:312–318
Jolin EM, Weller RA, Weller EB (2012) Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome. J Affect Disord 136:222–228
Jolin EM, Weller RA, Jessani NR, Zackai EH, McDonald-McGinn DM, Weller EB (2009) Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 deletion syndrome. J Affect Disord 119:177–180
Green T, Gothelf D, Glaser B, Debbane M, Frisch A, Kotler M, Weizman A, Eliez S (2009) Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry 48:1060–1068
Oskarsdottir S, Vujic M, Fasth A (2004) Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in western Sweden. Arch Dis Child 89:148–151
Shprintzen RJ, Higgins AM, Antshel K, Fremont W, Roizen N, Kates W (2005) Velo-cardio-facial syndrome. Curr Opin Pediatr 17:725–730
Shprintzen RJ (2000) Velo-cardio-facial syndrome: a distinctive behavioral phenotype. Ment Retard Dev Disabil Res Rev 6:142–147
Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C (2009) Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res Dev Disabil 30:763–773
Gothelf D, Presburger G, Zohar AH, Burg M, Nahmani A, Frydman M, Shohat M, Inbar D, Aviram-Goldring A, Yeshaya J, Steinberg T, Finkelstein Y, Frisch A, Weizman A, Apter A (2004) Obsessive–compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am J Med Genet B Neuropsychiatr Genet 126B:99–105
Bassett AS, Scherer SW, Brzustowicz LM (2010) Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry 167:899–914
Eliez S, Blasey CM, Schmitt EJ, White CD, Hu D, Reiss AL (2001) Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia? Am J Psychiatry 158:447–453
Eliez S, Debbane M (2008) Why are children and adolescent with 22q11.2 deletion syndrome at high risk of developing schizophrenia? Eur Psychiatr Rev 1:51–55
Vorstman JA, Morcus ME, Duijff SN, Klaassen PW, Heineman-de Boer JA, Beemer FA, Swaab H, Kahn RS, van Engeland H (2006) The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 45:1104–1113
Vorstman JA, Chow EW, Ophoff RA, van Engeland H, Beemer FA, Kahn RS, Sinke RJ, Bassett AS (2009) Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome. Am J Med Genet B Neuropsychiatr Genet 150B:430–433
Gothelf D, Feinstein C, Thompson T, Gu E, Penniman L, Van Stone E, Kwon H, Eliez S, Reiss AL (2007) Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 164:663–669
Debbane M, Glaser B, David MK, Feinstein C, Eliez S (2006) Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications. Schizophr Res 84:187–193
Msall ME, Tremont MR (1999) Measuring functional status in children with genetic impairments. Am J Med Genet 89:62–74
Devine D, Kempton T, Forehand R (1994) Adolescent depressed mood and young adult functioning: a longitudinal study. J Abnorm Child Psychol 22:629–640
Reich W (2000) Diagnostic interview for children and adolescents (DICA). J Am Acad Child Adolesc Psychiatry 39:59–66
Wechsler D (1991) Wechsler Intelligence Scale for children, 3rd edn. The Psychological corporation, San Antonio
Wechsler D (1997) Wechsler Adult Intelligence Scale, 3rd edn. The Psychological corporation, San Antonio
Sparrow SS, Balla DA, Cicchetti DV (1984) Vineland Adaptive Behaviour Scales. American Guidance Service, Circle Pines
Kovacs M (1992) Children’s depression inventory, CDI, Manual. Multi-Health Systems Inc.,Toronto
Reynolds CR, Richmond, BO (1999) Echelle revisee d’anxiete manifeste pour enfant (R-CMAS). ECPA, Paris
Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab-Stone ME, Lahey BB, Bourdon K, Jensen PS, Bird HR, Canino G, Regier DA (1996) The NIMH Diagnostic Interview Schedule for Children version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry 35:865–877
Papolos DF, Faedda GL, Veit S, Goldberg R, Morrow B, Kucherlapati R, Shprintzen RJ (1996) Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 153:1541–1547
Antshel KM, Shprintzen R, Fremont W, Higgins AM, Faraone SV, Kates WR (2010) Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study. J Am Acad Child Adolesc Psychiatry 49:333–344
Cartwright-Hatton S, McNicol K, Doubleday E (2006) Anxiety in a neglected population: prevalence of anxiety disorders in pre-adolescent children. Clin Psychol Rev 26:817–833
Essex MJ, Klein MH, Slattery MJ, Goldsmith HH, Kalin NH (2010) Early risk factors and developmental pathways to chronic high inhibition and social anxiety disorder in adolescence. Am J Psychiatry 167:40–46
Kates WR, Antshel KM, Faraone SV, Fremont WP, Higgins AM, Shprintzen RJ, Botti JA, Kelchner L, McCarthy C (2011) Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): a longitudinal study. Biol Psychiatry 69:945–952
Schaer M, Glaser B, Cuadra MB, Debbane M, Thiran JP, Eliez S (2009) Congenital heart disease affects local gyrification in 22q11.2 deletion syndrome. Dev Med Child Neurol 51:746–753
Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A (2003) Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 60:837–844
Borthwick-Duffy SA (1994) Epidemiology and prevalence of psychopathology in people with mental retardation. J Consult Clin Psychol 62:17–27
Murphy KC (2005) Annotation: velo-cardio-facial syndrome. J Child Psychol Psychiatry 46:563–571
Swillen A, Devriendt K, Legius E, Eyskens B, Dumoulin M, Gewillig M, Fryns JP (1997) Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet 34:453–458
Beaton EA, Simon TJ (2011) How might stress contribute to increased risk for schizophrenia in children with chromosome 22q11.2 deletion syndrome? J Neurodev Disord 3:68–75
Acknowledgments
The authors would like to thank all the families who kindly volunteered for this study since 2002. We extend our special thanks to Sarah Menghetti, Déborah Badoud, Catherine Pasca, Mélanie Chabloz, Gloria Repond and Danny Dukes for their help in data collection and processing. This research and the clinical research structure were supported by the Swiss National Fund to Professor Stephan Eliez (Grant Number: 32473B-121996) and the NARSAD Foundation (2002 Lieber Investigator Award). The sponsor of this study had no further role in study design, collection, analysis, interpretation of the data, writing of the report and in the decision to submit the paper for publication.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fabbro, A., Rizzi, E., Schneider, M. et al. Depression and anxiety disorders in children and adolescents with velo-cardio-facial syndrome (VCFS). Eur Child Adolesc Psychiatry 21, 379–385 (2012). https://doi.org/10.1007/s00787-012-0273-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00787-012-0273-x